• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前放化疗后直肠癌中细胞性和无细胞性黏蛋白池的临床意义

Clinical significance of cellular and acellular mucin pools in rectal carcinoma following preoperative chemoradiotherapy.

作者信息

Cienfuegos J A, Baixauli J, Rotellar F, Arredondo J, Sola J J, Arbea L, Pastor C, Hernández-Lizoáin J L

机构信息

Department of General Surgery, Clínica Universidad de Navarra, School of Medicine, University of Navarra, Av. Pío XII, 36, 31008, Pamplona, Spain.

Department of General Surgery, Complejo Hospitalario de León, León, Spain.

出版信息

Clin Transl Oncol. 2016 Jul;18(7):714-21. doi: 10.1007/s12094-015-1422-8. Epub 2015 Oct 16.

DOI:10.1007/s12094-015-1422-8
PMID:26474872
Abstract

BACKGROUND AND OBJECTIVES

The standard treatment for locally advanced rectal cancer (LARC) is neoadjuvant chemoradiotherapy (CRT) followed by surgery. Pathological findings remain the most significant prognostic factor. The presence of mucin pools and their prognostic significance is a controversial issue. The aim of this study was to analyze the incidence of cellular and acellular mucin pools and their clinical significance.

METHODS

Four-hundred and forty-six consecutive prospectively collected specimens from patients with LARC treated with long-course preoperative CRT and surgery were analyzed. Kaplan-Meier analysis was performed.

RESULTS

Mucin pools were present in 182 specimens (40.8 %); 66 (14.7 %) were acellular, and viable tumor cells were identified in 116 (26 %). The complete pathological response rate was 13.5 % (60 of 446). With a median follow-up of 79.0 months, the 5- and 10-year disease-free survivals for patients with acellular and cellular mucin pools were 81.5, 78.1, 63.7 and 61.2 %, respectively (p ≤ 0.026). The presence of cells in the colloid response to treatment was associated with a 17.8 and 16.9 % decrease in 5- and 10-year disease survival vs. acellular colloid response.

CONCLUSIONS

Our results suggest that cellular mucin pools are an indicator of an aggressive phenotype and harbingers of a worse prognosis.

摘要

背景与目的

局部晚期直肠癌(LARC)的标准治疗方法是新辅助放化疗(CRT)后行手术治疗。病理结果仍然是最重要的预后因素。黏液池的存在及其预后意义是一个有争议的问题。本研究的目的是分析细胞性和无细胞性黏液池的发生率及其临床意义。

方法

对446例接受长疗程术前CRT和手术治疗的LARC患者连续前瞻性收集的标本进行分析。采用Kaplan-Meier分析。

结果

182例标本(40.8%)存在黏液池;66例(14.7%)为无细胞性,116例(26%)发现有存活肿瘤细胞。完全病理缓解率为13.5%(446例中的60例)。中位随访79.0个月,无细胞性和细胞性黏液池患者的5年和10年无病生存率分别为81.5%、78.1%、63.7%和61.2%(p≤0.026)。胶体反应中有细胞存在与5年和10年疾病生存率分别比无细胞胶体反应降低17.8%和16.9%相关。

结论

我们的结果表明,细胞性黏液池是侵袭性表型的指标和预后较差的预兆。

相似文献

1
Clinical significance of cellular and acellular mucin pools in rectal carcinoma following preoperative chemoradiotherapy.术前放化疗后直肠癌中细胞性和无细胞性黏蛋白池的临床意义
Clin Transl Oncol. 2016 Jul;18(7):714-21. doi: 10.1007/s12094-015-1422-8. Epub 2015 Oct 16.
2
Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy.新辅助放化疗后直肠癌中无细胞黏蛋白池的意义。
Am J Surg Pathol. 2011 Jan;35(1):127-34. doi: 10.1097/PAS.0b013e318200cf78.
3
Prevalence and clinical significance of cellular and acellular mucin in patients with locally advanced mucinous rectal cancer who underwent preoperative chemoradiotherapy followed by radical surgery.接受术前放化疗后行根治性手术的局部晚期黏液性直肠癌患者中细胞性和无细胞黏蛋白的患病率及临床意义
Colorectal Dis. 2016 Jan;18(1):O10-6. doi: 10.1111/codi.13169.
4
Impact of acellular mucin pools on survival in patients with complete pathological response to neoadjuvant treatment in rectal cancer.无细胞黏蛋白池对直肠癌新辅助治疗完全病理缓解患者生存的影响。
Int J Surg. 2014 Oct;12(10):1123-6. doi: 10.1016/j.ijsu.2014.07.267. Epub 2014 Jul 27.
5
Clinical implications of acellular mucin pools in resected rectal cancer with pathological complete response to neoadjuvant chemoradiation.新辅助放化疗后病理完全缓解的直肠切除术后无细胞黏蛋白池的临床意义。
Colorectal Dis. 2012 Jan;14(1):62-7. doi: 10.1111/j.1463-1318.2010.02532.x.
6
Prevalence and clinical significance of acellular mucin in locally advanced rectal cancer patients showing pathologic complete response to preoperative chemoradiotherapy.术前放化疗后病理完全缓解的局部进展期直肠癌患者中无细胞黏蛋白的流行情况及其临床意义。
Am J Surg Pathol. 2013 Jan;37(1):47-52. doi: 10.1097/PAS.0b013e3182657186.
7
The significance of mucin pools following neoadjuvant chemoradiotherapy for locally advanced rectal cancer.新辅助放化疗后局部晚期直肠癌中黏蛋白池的意义
J Surg Oncol. 2018 Dec;118(7):1129-1134. doi: 10.1002/jso.25247. Epub 2018 Sep 27.
8
Presence and clinical significance of acellular mucin pools in resected rectal cancer with pathological complete response after pre-operative chemoradiotherapy.术前放化疗后病理完全缓解的直肠癌切除标本中无细胞黏液池的存在及其临床意义
Histopathology. 2022 Nov;81(5):569-576. doi: 10.1111/his.14795. Epub 2022 Sep 22.
9
Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation.术前放化疗病理完全缓解的直肠腺癌患者中无细胞黏蛋白的临床意义。
Ann Surg. 2010 Feb;251(2):261-4. doi: 10.1097/SLA.0b013e3181bdfc27.
10
Clinical significance of carcinoembryonic antigen expression of acellular mucin pools after preoperative chemoradiotherapy of rectal carcinoma.直肠癌术前放化疗后无细胞黏液池癌胚抗原表达的临床意义
Cancer Biother Radiopharm. 2014 Sep;29(7):295-7. doi: 10.1089/cbr.2014.1640.

引用本文的文献

1
Acellular mucin in neoplastic and non-neoplastic conditions of the lower gastrointestinal tract.下消化道肿瘤性和非肿瘤性病变中的无细胞黏蛋白
World J Gastrointest Surg. 2025 Jul 27;17(7):106672. doi: 10.4240/wjgs.v17.i7.106672.
2
Comprehensive Overview of Molecular, Imaging, and Therapeutic Challenges in Rectal Mucinous Adenocarcinoma.直肠黏液腺癌的分子、影像学及治疗挑战综述
Int J Mol Sci. 2025 Jan 7;26(2):432. doi: 10.3390/ijms26020432.
3
Mucinous Degeneration on MRI After Neoadjuvant Therapy in Patients With Rectal Adenocarcinoma: Frequency and Association With Clinical Outcomes.

本文引用的文献

1
Impact of perineural and lymphovascular invasion on oncological outcomes in rectal cancer treated with neoadjuvant chemoradiotherapy and surgery.神经周围和淋巴管浸润对接受新辅助放化疗及手术治疗的直肠癌肿瘤学结局的影响。
Ann Surg Oncol. 2015 Mar;22(3):916-23. doi: 10.1245/s10434-014-4051-5. Epub 2014 Sep 5.
2
Inverse effect of mucinous component on survival in stage III colorectal cancer.黏液成分对III期结直肠癌患者生存的反向影响。
J Surg Oncol. 2014 Dec;110(7):851-7. doi: 10.1002/jso.23742. Epub 2014 Aug 11.
3
Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial.
新辅助治疗后直肠腺癌患者 MRI 上黏液变性:频率及与临床结局的关系。
AJR Am J Roentgenol. 2023 Aug;221(2):206-216. doi: 10.2214/AJR.23.29002. Epub 2023 Mar 15.
4
Clinical significance of adjuvant chemotherapy for pathological complete response rectal cancer patients with acellular mucin pools after neoadjuvant chemoradiotherapy.新辅助放化疗后伴有无细胞粘蛋白池的病理完全缓解直肠癌患者辅助化疗的临床意义
Therap Adv Gastroenterol. 2023 Feb 3;16:17562848221117875. doi: 10.1177/17562848221117875. eCollection 2023.
5
Predictive Value of FOLFOX-Based Regimen, Long Interval, Hemoglobin Levels and Clinical Negative Nodal Status, and Postchemoradiotherapy CEA Levels for Pathological Complete Response in Patients with Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy.新辅助放化疗后局部晚期直肠癌患者中,基于FOLFOX方案、长间隔、血红蛋白水平及临床阴性淋巴结状态以及放化疗后癌胚抗原水平对病理完全缓解的预测价值
J Oncol. 2020 Jan 28;2020:9437684. doi: 10.1155/2020/9437684. eCollection 2020.
6
Prognostic impact of acellular mucin pools towards the patients with locally advanced rectal cancer achieving pathological complete response after preoperative chemoradiotherapy.无细胞黏蛋白池对术前放化疗后达到病理完全缓解的局部晚期直肠癌患者的预后影响
Therap Adv Gastroenterol. 2020 Mar 25;13:1756284820911259. doi: 10.1177/1756284820911259. eCollection 2020.
7
Mucinous rectal cancer: concepts and imaging challenges.黏液性直肠肿瘤:概念与影像挑战。
Abdom Radiol (NY). 2019 Nov;44(11):3569-3580. doi: 10.1007/s00261-019-02019-x.
8
Newly recognized extratumoral features of colorectal cancer challenge the current tumor-node-metastasis staging system.新发现的结直肠癌肿瘤外特征对当前的肿瘤-淋巴结-转移分期系统提出了挑战。
Ann Gastroenterol. 2018 Sep-Oct;31(5):525-534. doi: 10.20524/aog.2018.0284. Epub 2018 Jun 19.
9
Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery?在接受新辅助放化疗和手术治疗的直肠腺癌中,病理变量具有预后意义吗?
World J Gastroenterol. 2017 Feb 28;23(8):1412-1423. doi: 10.3748/wjg.v23.i8.1412.
局部进展期直肠癌术前放化疗后肿瘤退缩分级的再评价:CAO/ARO/AIO-94 研究的更新结果。
J Clin Oncol. 2014 May 20;32(15):1554-62. doi: 10.1200/JCO.2013.54.3769. Epub 2014 Apr 21.
4
Neoadjuvant radiotherapy use in locally advanced rectal cancer at NCCN member institutions.NCCN 成员机构中局部晚期直肠癌的新辅助放疗应用。
J Natl Compr Canc Netw. 2014 Feb;12(2):235-43. doi: 10.6004/jnccn.2014.0024.
5
Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy.临床标准低估了新辅助放化疗治疗直肠癌的完全病理缓解率。
Dis Colon Rectum. 2014 Mar;57(3):311-5. doi: 10.1097/DCR.0b013e3182a84eba.
6
Combination chemoradiation therapy: the whole is more than the sum of the parts.联合放化疗:整体大于部分之和。
J Clin Oncol. 2014 Feb 10;32(5):367-9. doi: 10.1200/JCO.2013.54.3108. Epub 2014 Jan 13.
7
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy.经新辅助放化疗后接受切除术的直肠癌患者,残留肿瘤负担评估的量化病理反应是无复发生存率的预测指标。
Cancer. 2013 Dec 15;119(24):4231-41. doi: 10.1002/cncr.28331. Epub 2013 Oct 1.
8
Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.局部进展期直肠癌患者术前接受放化疗和辅助化疗后复发的预后因素。
Dis Colon Rectum. 2013 Apr;56(4):416-21. doi: 10.1097/DCR.0b013e318274d9c6.
9
Prevalence and clinical significance of acellular mucin in locally advanced rectal cancer patients showing pathologic complete response to preoperative chemoradiotherapy.术前放化疗后病理完全缓解的局部进展期直肠癌患者中无细胞黏蛋白的流行情况及其临床意义。
Am J Surg Pathol. 2013 Jan;37(1):47-52. doi: 10.1097/PAS.0b013e3182657186.
10
Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.局部进展期直肠癌术前与术后放化疗的比较:中位随访 11 年后德国 CAO/ARO/AIO-94 随机 III 期临床试验结果。
J Clin Oncol. 2012 Jun 1;30(16):1926-33. doi: 10.1200/JCO.2011.40.1836. Epub 2012 Apr 23.